Page last updated: 2024-09-03

morphiceptin and Colorectal Neoplasms

morphiceptin has been researched along with Colorectal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Becker, C; Fichna, J; Jacenik, D; Kordek, R; Krajewska, WM; Sałaga, M; Schodel, L; Szymaszkiewicz, A; Zatorski, H; Zielińska, M	1

Other Studies

1 other study(ies) available for morphiceptin and Colorectal Neoplasms

Article	Year
Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice. European journal of pharmacology, 2020, Oct-15, Volume: 885 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azoxymethane; Carcinogens; Cell Proliferation; Colitis; Colorectal Neoplasms; Dextran Sulfate; Endorphins; Male; Mice; Mice, Inbred BALB C; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tumor Necrosis Factor-alpha	2020

Article

Year

Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice.

European journal of pharmacology, 2020, Oct-15, Volume: 885

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azoxymethane; Carcinogens; Cell Proliferation; Colitis; Colorectal Neoplasms; Dextran Sulfate; Endorphins; Male; Mice; Mice, Inbred BALB C; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tumor Necrosis Factor-alpha

2020